Related Experiment Video
Updated: Aug 9, 2026
09:46
Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
Prevalence of multiple sclerosis in Rochdale
1Department of Neurology, North Manchester General Hospital, UK.
Journal of Neurology, Neurosurgery, and Psychiatry
|October 1, 1996
Summary
This study determined the prevalence of multiple sclerosis (MS) in Rochdale, finding an overall rate of 122/100,000. MS rates in Rochdale are comparable to southern England but lower than Scotland.
Area of Science:
- Neurology
- Epidemiology
Background:
- Multiple sclerosis (MS) is a chronic neurological disease with varying geographical prevalence.
- Understanding local MS prevalence is crucial for healthcare planning and resource allocation.
Purpose of the Study:
- To establish the prevalence of multiple sclerosis (MS) in the Rochdale Metropolitan Borough.
- To provide epidemiological data for MS in North West England.
Main Methods:
- A comprehensive case ascertainment strategy was employed, combining a prospective neurological register (from 1979) with data from general practitioners, therapists, and social services.
- Prevalence was determined on a specific date (January 1, 1989) to capture the existing MS population in Rochdale.
Main Results:
- A total of 254 individuals with MS were identified in Rochdale on the prevalence day.
- The overall prevalence of MS was calculated at 122 per 100,000 population, with probable cases at 96 per 100,000.
- Peak prevalence rates were observed in women aged 35-44 (437/100,000) and men aged 45-54 (221/100,000).
- Familial MS was noted in 10.8% of affected families.
Conclusions:
- The prevalence of MS in Rochdale is similar to figures reported in southern England and Wales.
- This study indicates a lower MS prevalence in Rochdale compared to Scotland.
- The findings contribute valuable epidemiological data for MS in the North West England region.
Related Concept Videos
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...